REQUEST A DEMO
Total
USD $0.00
Search more companies

Sun Moon Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sun Moon Pharmaceuticals Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Sun Moon Pharmaceuticals Private Limited is a company based in India, with its head office in Boisar. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on April 20, 2000. The company’s latest financial report indicates a net sales revenue increase of 48.39% in 2025. A negative growth of 11.91% was recorded in its total assets. The net profit margin of Sun Moon Pharmaceuticals Private Limited increased by 0.89% in 2025.

Legal Address
Plot No. N-65, Midc Tarapur Boisar Palghar
Boisar; Maharashtra; Postal Code: 401505

Contact Details: Purchase the Sun Moon Pharmaceuticals Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Sun Moon Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Sun Moon Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
April 20, 2000
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Sun Moon Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
48.39%
Total Operating Revenue
48.72%
Operating Profit
103.45%
EBITDA
26.67%
Net Profit/Loss for the Period
124.17%
Total Assets
-11.91%
Total Equity
20.76%
Operating Profit Margin
1.27%
Net Profit Margin
0.89%
Return on Equity (ROE)
7.93%
Debt / Equity
-41.45%
Quick Ratio
0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?